Cambridge Cognition Holdings Plc (LON:COG – Get Free Report) passed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 35.41 and traded as low as GBX 27. Cambridge Cognition shares last traded at GBX 27.60, with a volume of 148,878 shares.
Cambridge Cognition Stock Performance
The company’s fifty day simple moving average is GBX 32.14 and its 200 day simple moving average is GBX 35.24. The stock has a market capitalization of £15.00 million, a P/E ratio of -7.13 and a beta of 0.81. The company has a current ratio of 0.40, a quick ratio of 0.96 and a debt-to-equity ratio of 29.16.
Cambridge Cognition Company Profile
Cambridge Cognition Holdings Plc, a neuroscience technology company, develops and markets near-patient cognitive testing techniques in the United States, United Kingdom, the European Union, and internationally. The company offers CANTAB digital cognitive assessment platform for drug development by enabling pharmaceutical companies to take new therapeutics from preclinical consultancy to pivotal studies and approval, as well as supports sponsors to enhance recruitment, develop safe and effective treatments, and enhance research and development efficiency.
Further Reading
- Five stocks we like better than Cambridge Cognition
- Block Makes a Federal Trust Bank Move That Could Reshape Its Fintech Model
- Kroger’s Textbook Entry for Buy-and-Hold Investors
- AST SpaceMobile Looks to Extend Its 30-Day FCC Satellite Testing Window
- Amgen Drops 10% on a Trial It Didn’t Even Run
Receive News & Ratings for Cambridge Cognition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cambridge Cognition and related companies with MarketBeat.com's FREE daily email newsletter.
